Need for surveillance of hepatocellular carcinoma in patients with alcoholic cirrhosis
Author(s): ,
Ramon Bataller
Affiliations:
Liver Pittsburgh Research Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Corresponding author. Address: Liver Pittsburgh Research Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Gennaro D'Amico
Affiliations:
Gastroenterology Unit, Ospedale V. Cervello, Palermo, Italy
EASL LiverTree™. Bataller R. Dec 1, 2018; 256762
Ramon Bataller
Ramon Bataller
Contributions
Journal Abstract
References
This article does not have an abstract to display.
[1]. L. Pimpin - Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies
[2]. H.K. Seitz - Alcoholic liver disease
[3]. G. Testino - Alcohol and hepatocellular carcinoma: a review and a point of view
[5]. F. Stickel - Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis
[6]. J. Altamirano - Cigarette smoking and chronic liver diseases
[7]. L. Bucci - Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome
[8]. N. Ganne-Carrie - Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis
[9]. D. Kansagara - Screening for hepatocellular carcinoma in chronic liver disease. A systematic review
[10]. P. Jepsen - Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study
[11]. J. West - Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population-based cohort study

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies